About ELEM Biotech
ELEM Biotech is a company based in Barcelona (Spain) founded in 2018 by Jose Maria Cela, Guillaume Houzeaux, Christopher Morton, and Mariano Vazquez. ELEM Biotech has raised $2.27 million across 3 funding rounds from investors including European Union and EIC Fund. ELEM Biotech offers products and services including Virtual Humans Platform and In-Silico Trials Service. ELEM Biotech operates in a competitive market with competitors including Unlearn, adsilico, Virtonomy, Akkure and Electric Twin, among others.
- Headquarter Barcelona, Spain
- Founders Jose Maria Cela, Guillaume Houzeaux, Christopher Morton, Mariano Vazquez
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Elem Biotech Sl
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.27 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ELEM Biotech
ELEM Biotech offers a comprehensive portfolio of products and services, including Virtual Humans Platform and In-Silico Trials Service.
Platform for creating virtual populations in medical testing
Service for conducting virtual trials in drug development
People of ELEM Biotech
Unlock access to complete
Unlock access to complete
Funding Insights of ELEM Biotech
ELEM Biotech has successfully raised a total of $2.27M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ELEM Biotech
ELEM Biotech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for ELEM Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ELEM Biotech
Investment portfolio details for ELEM Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ELEM Biotech
Detailed financials for ELEM Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elem Biotech Comparisons
Peer comparison for ELEM Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ELEM Biotech
ELEM Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unlearn, adsilico, Virtonomy, Akkure and Electric Twin, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based clinical trial management software
|
|
| Locked | Locked | Locked |
In-silico trial solutions for medical device testing are developed.
|
|
| Locked | Locked | Locked |
Virtual patient simulations are provided for medical device development.
|
|
| Locked | Locked | Locked |
Blockchain-based platform for genomic data analytics is provided.
|
|
| Locked | Locked | Locked |
AI-powered digital twin technology for research and clinical applications in the life sciences industry
|
Detailed competitors of ELEM Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elem Biotech
Complete news archive for ELEM Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ELEM Biotech
ELEM Biotech was founded in 2018 and raised its 1st funding round 2 years after it was founded.
ELEM Biotech is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Christopher Morton is the current CEO of ELEM Biotech. They have also founded this company.
ELEM Biotech is a funded company, having raised a total of $2.27M across 3 funding rounds to date.
ELEM Biotech was founded in 2018 in Barcelona, Spain, within the biotech sector. A platform for medical simulations is offered to support doctors in virtual clinical trials. These trials address cardiac resynchronization, cardiotoxicity, painkiller pumps, valve implants, inhaler flow rates, and drug delivery concentrations. A virtual cardiovascular system is modeled, integrating electrical activity, mechanical deformation, and fluid mechanics. Respiratory simulations are based on fluid mechanics principles.
ELEM Biotech offers Virtual Humans Platform and In-Silico Trials Service.
ELEM Biotech has 2 investors. Key investors include European Union, and EIC Fund.